These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19236753)

  • 41. Mutations of the PIK3CA gene in diffuse large B cell lymphoma.
    Baohua Y; Xiaoyan Z; Tiecheng Z; Tao Q; Daren S
    Diagn Mol Pathol; 2008 Sep; 17(3):159-65. PubMed ID: 18382359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
    Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
    Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Gene expression profiling of diffuse large B-cell lymphoma in China].
    Liu YH; Li L; Liu G; Zhuang HG; Luo DL; Luo XL; Xu J
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):79-83. PubMed ID: 17493379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas.
    Pescarmona E; De Sanctis V; Pistilli A; Pacchiarotti A; Martelli M; Guglielmi C; Mandelli F; Baroni CD; Le Coco F
    J Pathol; 1997 Nov; 183(3):281-6. PubMed ID: 9422982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.
    Steube KG; Jadau A; Teepe D; Drexler HG
    Leukemia; 1995 Nov; 9(11):1841-6. PubMed ID: 7475272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical significance of rapid detecting bone marrow BCL2/IGH and BCL6/IGH fusion genes in patients with diffuse large B cell lymphoma by multiplex PCR].
    Guo YL; Dong LL; Gao L; Xu YY; Ding Y; Wang LL; Jing Y; Bo J; Zhou MH; Cao TT; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1370-3. PubMed ID: 23257435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mechanism of MiR-224 Affecting DLBCL Cell Proliferation and Invasion by Targeted Inhibition of PIK3CD].
    Xie Y; Tan L; Li YT; Zeng Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1578-1584. PubMed ID: 33067957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SECISBP2 is a novel prognostic predictor that regulates selenoproteins in diffuse large B-cell lymphoma.
    Taguchi T; Kurata M; Onishi I; Kinowaki Y; Sato Y; Shiono S; Ishibashi S; Ikeda M; Yamamoto M; Kitagawa M; Yamamoto K
    Lab Invest; 2021 Feb; 101(2):218-227. PubMed ID: 33077808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of miR-28 in B cell lymphoma cell lines detected by solution hybridization].
    Xu W; Li JY; Lu FX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):289-92. PubMed ID: 16638199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Knockout of Micro-RNA-21 Gene in DLBCL OCI-Ly3 cells by TALEN Technique].
    Chen BY; Hu JD; Lin RZ; Chen XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):422-6. PubMed ID: 27151003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preliminary study on decreasing the expression of FOXP3 with miR-155 to inhibit diffuse large B-cell lymphoma.
    Zhang J; Wei B; Hu H; Liu F; Tu Y; Zhao M; Wu D
    Oncol Lett; 2017 Aug; 14(2):1711-1718. PubMed ID: 28789399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metadherin interference inhibits proliferation and enhances chemo-sensitivity to doxorubicin in diffuse large B cell lymphoma.
    Li PP; Feng LL; Chen N; Lu K; Meng XH; Ge XL; Lv X; Wang X
    Int J Clin Exp Med; 2014; 7(8):2081-6. PubMed ID: 25232390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.
    Yang M; Yao Y; Eades G; Zhang Y; Zhou Q
    Breast Cancer Res Treat; 2011 Oct; 129(3):983-91. PubMed ID: 21638050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Critical Role of miR-144 in Diffuse Large B-cell Lymphoma Proliferation and Invasion.
    Wang H; Wang A; Hu Z; Xu X; Liu Z; Wang Z
    Cancer Immunol Res; 2016 Apr; 4(4):337-44. PubMed ID: 26865454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.
    Fan Q; Meng X; Liang H; Zhang H; Liu X; Li L; Li W; Sun W; Zhang H; Zen K; Zhang CY; Zhou Z; Chen X; Ba Y
    Protein Cell; 2016 Dec; 7(12):899-912. PubMed ID: 27815824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma].
    Xu FP; Liu YH; Luo XL; Zhuang HG; Li L; Luo DL; Xu J; Zhang F; Zhang MH; Du X; Li WY
    Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):371-6. PubMed ID: 19031715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
    Rossi D; Gaidano G
    Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).
    Nedomova R; Papajik T; Prochazka V; Indrak K; Jarosova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):239-47. PubMed ID: 23132512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expressions of bcl-6, lpp and miR-28 genes in diffuse large B cell lymphoma cell lines].
    Xu W; Li JY; Fan L; Qiao C; Yu H; Shen QD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):83-7. PubMed ID: 19236753
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.